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Resu/ts: Data re1 both ptofOO01 groups demonstrate an 80% red~-'tion 
=n heart falture admiss=ons and hoa;lh care costs at three (p - 0001) an~ 
six month (p ~ 0,001) I~low up, Improvement in quality of life was also 
demonMmted (p ~ 0,00~), No sigefficanl diffemnc~ in any parameter were 
demonstrated betw~n greu~ e~c~ for the mrmber e! diure~ changes 
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~ RNu~!i~n In ~r t  Fa!!um I[v~ts by Clinical 
Pha~Is t  !n~l ion :  Pharmacist In H~rt  Failure 
~ ~ t  Recommendation and Monit~ing 
(PHARM) Study 
WA. Gatlts~ V. HasseP~d, R L. Larsen. DJ  Whellan, CM O'Connor Duke 
thuvers~ty Medica~ Center, Dumam, Noah Carolina, USA 
Bac~'~: / :  The mult~d~scfpkna~y ~ tO managing heart tadure (HF) 
pa~ts  (ptS) has been shown to II1'tpl~DVe o~tcolnlleS. The role of a clinical 
pharmacist (CPh) m HF has not been evaluated. 
/ i , fe~:  181 pts evaluated m c*.,m~ with HF and left ventocufar dys- 
function (EF ~. 45) were ~ to interventto~ (IG) or control (CG) 
group. The IG received CPh rsed~abon evaluabon, Ihorapeu~c racommen- 
dabor~s to attending p~an,  and foX,w-up (FILl) te~emondonng. The CG 
moe~l  usual care. The primary endpomt was combined afl cause mortal~ 
and HF cfin~cal events (CE). A~ CE were adiud~cated by a blinded enc~oomt 
commdlee. 
Resume: Basehoa cha,-acteflst~cs were sm~ar except far slightly h~per 
age In IG. ~,~:~an FU was 5 months. Air cause mortality and HF events are 
shown m Table 1. CPh inten,=entlon reduced the combined endgomt of death 
and HF events. 
Tabk~ 1 IG In : 901 ~ In = 91 } P 
~.~'taf~/& HF Events 4 16 e 0G5 
AR Cab'SO I~tt~hl~, 3 S 047~ 
HF Events 1 tl 0 005 
Tectal Events 29 36 0 
8.t~.~an% TargetACEI 100150 100)  501125 100t - 00101 
Co~:/us~,n. The =mproved outcomes may be due to h~ghet ACEI dose 
ancVor closer FU. Outcomes in HF are improved w~th a CPh as a member of 
the multidisoplinary HF team 
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~ Susts ined in Vascular Endothe l ia l  Improvement  
Function After Short-term Dobutamine Infusion in 
Patients With Severe Chronic Congestive Heart 
Fai lure 
LV. Kaplon, R.N. Pami, M.B. Patel. D. Levy. J. A Strata, J. Shiranl. 
TH. LeJemtel, A~bert Einstein College of Medicine, Bronx. NY. USA 
The mechanisms responsible for sustained clinical benefits after a 72 hour 
infusion of dobutamine (D) are unclear. We hypothesize that by increasing 
peripheral blood flow for 72 hours D may exert a prolonged effect on vascular 
endothelial function. Accordingly, HR, brachial artery (BA) diameter (d) and 
velocity-time integral were measured by Doppler echocardiography in 13 
patrents w~th severe CHF (LVEF: 26 ± 2%) treated ~lh  D for 72 hours (mean 
dose: 3.75 .gJkg/min). Measurements were made at rest (R) and at peak 
reactive hyperemia (PRH), induced by 5 minutes of BA occhrsion. These 
data were recorded at baseline (BL), at 3 and 72 hours of D, and at 2 and 4 
weeks alter D infusion. BAd and total BA blood flow (BABF) at rest and PRH 
and the percent change in BAd (~BAd) induced by PRH were calculated. 
While resting BABF increased by 34 and 26 ml/min after 3 and 72 hours of 
D (p < 0.05 vs BL), PRH BABF and HR were unchanged. The effects of D 
infusion on BAd are shown in the table: 
ElL 3 hr 72 hr 2 wk 4 wk 
R BAd (mm) 4.41 4.51 4.33 4.39 4.40 
,~BAd (%) 9,1 9.7 15,5" 12.8" 9.5 
• p < 0.05 vs BL 
We conclude: A 72 hour mtu~on =~ ;,-~u~-~ .n ,mpreveme~t m vasC~..~ar 
endothelial funcf~on man~fost by o~BAd, whch cS ~u~amed for ~ weeks post 
mfusmn w~tho~ change in e~her resting or PRH BABF These ef~e¢ls o~ 
vascular endothelial function ~m slm~l~r tO that note~ after p,hys~Cai t!a~ntr~ 
=n ~evero chronic CHF 
Minimally Invnlvo Coronary 
RevlmculadzMion 
Monday, March 30, 1998, 2:00 p,m,-3:30 p.m, 
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incisions Ns ~ and AssoeiMed With !mpmve¢l 
Patient Setlsfe~km 
DH Adams, D Re, borough, GS Couper, LH  Calm. Bngt~.~m ,~;~ 
~ ~ H<~p,fa/. Bosfo,, MA, USA 
Background: Beginning in J~Jly t996, we performed mimmalty mvaswe vah~ 
surgery in t00 pal~eres (age range 30~4 years) mqumng aomc valve re- 
placement n : 47 (AVR) or mltral valve replacement n : t0 e~ repair n = 43 
(MVR) We have reviewed our in~al clinical results and surveyed patients 
after (hscharge to assess e ~  of this approach. 
Met,hods: Procedures were performed through a 6 cm nght parastemat 
mosmn wffh removal o~ the 2nd--3~ (AVR) or 3mt-4th (MVR) costal ca~- 
lages, or an upper pamal stemotomy (AVR) F ~  for the small ~ ,  
all other aspects of the procedures were ~entTcal to those pe,Aormed through 
a sfemotomy. 
Resume: There were 2 penoperatwe deaths in the AVR group (arrhylhmla 
on POD 4, hepatic tadure on POD t5) and no deaths in the MVR group. The 
only mtraoperatp,,e complK;ations encountered were a coronary sinus mlury 
(n = 1) and a local dtssactlon Of the ascending aorta at a vent site (n = t). 
The rned~an lenglh at stay (LOS) was 5 days in each group. Importantly, 
patwent satmfacllon was very high with these approaches because of t) 
boiler cosmattc re=-ults. 1) decreased inc~smnal pain. and 3) eaflmr func~onal 
recovery reflected =n a reduction rn the need for post-I'msp~al rehal~llta~on 
tacd~l~es. 
Conclusion; Our expenence demcnstTares mimmalty mvastve cardiac 
valve surgery is safe and associated w~th improved patient satisfaction and 
recovery. We believe these techniques are likely to be w~dely adopted 
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-~ Port  MIDCAB: Cl inical  and Access  Experience 
Ang iograph ic  Fo l low-up 
AC Galloway. G.H. R=bakove. RA. Espos[to. J.S Mdler, R.V. Anderson, 
F.G. Baumann. PM Buttenhem~, Wl. Ayata, E.A. Grosei, SB  Cohnn. New 
York Unn,.ers~ty MeScal Center. New York. IVY.. USA 
Background: This report was intended to revvew our clinK:al expenenco w=th 
both minimally mvaswe direct coronary artery bypass (MIDCAB) and Port- 
Access coronary artery bypass (PAl in an affempt to develop an apprppflata 
treatment algorithm. 
Methods: From 10/96 to 4,97, 18 pls underwent MIDCAB and 32 10is 
underwent PA. There were 39 men and 11 women (mean age 62 yrs, range 
34-82). All 18 MIDCAB pls had single vessel bypass (16 LIMA to LAD, 
2 RIMA to RCA). in the PA group 18 pts underwent single bypass, 9 pts 
had double bypass and 5 pts had tnple bypass (31 LIMA to LAD. 1 RIMA 
to RCA; 9 radml artery grafts. 5 saphenous veln grafts, 5 sequontinl grafts) 
Flee PA pts had concomitant valvular procedureS. Angiographic studies were 
performed pnor to discharge m 13 of 18 MIDCAB and 30 of 32 PA pts. 
Results: There were no myocardial infarohons, deaths or strokes in either 
group. With MIDCAB. 2 pts were converted to stemotomy, 1 pt was converted 
to PA due to a fragile LAD and 2 p'.s required angioplasty ( 1 for graft occlusion 
and I for a separate LAD lesion). With PA. 2 lots were converted to MIBCAB 
due to penpheral atherosclerosis. I pt had reoperotion for graft revision and 
pulmonary embotectorny and 1 pt requ|red angioglasty for graft occlusion. By 
angiography. LAD graft patenCy was 923% for MIOCAB and 100% for pp. 
The overall graft patef~cy was 97.9% for PA. 
Conclusions: We recommend selectwe, complementary use el MIDCAB 
and PA for single vessel LAD disease, based on clinical variables such as 
coronary f,rag~lity or peripheral vascular disease. With the PA technique LAD 
graft patency was 100%. and both multi*vessel mvasculanzation and con- 
comitent intracardiac valvular surgery was possible. These results demon- 
strate the expanding role of minimally invasive bypass surgery. 
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